{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:32:59Z","timestamp":1791120779270,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jasc.2024.09.003","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T21:19:32Z","timestamp":1726780772000},"page":"11-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Triage options for positive high-risk HPV results from HPV-based cervical cancer screening: a review of the potential alternatives to Papanicolaou test cytology"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-597X","authenticated-orcid":false,"given":"Michael J.","family":"Thrall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-4494","authenticated-orcid":false,"given":"Jeffrey K.","family":"Mito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2024.09.003_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2024.09.003_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fonc.2019.00355","article-title":"Mucosal and cutaneous Human Papillomavirus infections and cancer biology","volume":"9","author":"Gheit","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jasc.2024.09.003_bib3","doi-asserted-by":"crossref","first-page":"912","DOI":"10.15585\/mmwr.mm7234a3","article-title":"Vaccination coverage among adolescents aged 13-17 years - National Immunization Survey - Teen, United States, 2022","volume":"72","author":"Pingali","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jasc.2024.09.003_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3322\/caac.21616","article-title":"Human Papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation","volume":"70","author":"Saslow","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2024.09.003_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human Papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jasc.2024.09.003_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk Human Papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jasc.2024.09.003_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239611","article-title":"Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden","volume":"15","author":"Fogelberg","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2024.09.003_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163509","article-title":"Optimal management strategies for primary HPV testing for cervical screening: Cost-effectiveness evaluation for the National Cervical Screening Program in Australia","volume":"12","author":"Simms","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2024.09.003_bib9","article-title":"National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: Observational study","volume":"376","author":"Smith","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jasc.2024.09.003_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: Implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jasc.2024.09.003_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ypmed.2018.12.021","article-title":"HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme","volume":"119","author":"Polman","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.jasc.2024.09.003_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/aogs.14311","article-title":"Co-testing in cervical screening among 40- to 42-year-old women is unreasonable","volume":"101","author":"Borgfeldt","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jasc.2024.09.003_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106617","article-title":"The value of adding a single co-test in HPV primary screening","volume":"149","author":"Jans","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.jasc.2024.09.003_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: The transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jasc.2024.09.003_bib15","article-title":"Comparison of diagnostic accuracy and acceptability of self-sampling devices for Human Papillomavirus detection: A systematic review","volume":"38","author":"Aimagambetova","year":"2024","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.jasc.2024.09.003_bib16","first-page":"1036","article-title":"Primary Human Papillomavirus testing and other new technologies for cervical cancer screening","volume":"142","author":"Einstein","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jasc.2024.09.003_bib17","first-page":"24","article-title":"HPV test self-collection set in motion","volume":"38","author":"Albert","year":"2024","journal-title":"CAP Today"},{"key":"10.1016\/j.jasc.2024.09.003_bib18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.5858\/arpa.2012-0115-CP","article-title":"The Tahoe Study: Bias in the interpretation of papanicolaou test results when Human Papillomavirus status is known","volume":"138","author":"Moriarty","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2024.09.003_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cncy.21783","article-title":"Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy","volume":"125","author":"Doxtader","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cncy.21596","article-title":"HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status","volume":"123","author":"Richardson","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju423","article-title":"Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial","volume":"107","author":"Bergeron","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2024.09.003_bib22","doi-asserted-by":"crossref","first-page":"569.e1","DOI":"10.1016\/j.ajog.2011.06.101","article-title":"Prior knowledge of HPV status improves detection of CIN2+ by cytology screening","volume":"205","author":"Benoy","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jasc.2024.09.003_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ajcp\/aqw125","article-title":"Knowledge of patients' Human Papillomavirus status at the time of cytologic review significantly affects the performance of cervical cytology in the ATHENA study","volume":"146","author":"Wright","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/cncy.22624","article-title":"Inter- and intraobserver agreement in whole-slide digital ThinPrep samples of low-grade squamous lesions of the cervix uteri with known high-risk HPV status: A multicentric international study","volume":"130","author":"Kholova","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5858\/arpa.2012-0178-OA","article-title":"Prospective and retrospective review of gynecologic cytopathology: Findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference Working Group 2","volume":"137","author":"Brainard","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2024.09.003_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jasc.2021.05.002","article-title":"Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping","volume":"10","author":"Narkcham","year":"2021","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1471-0528.13076","article-title":"A systematic review of p16\/Ki-67 immuno-testing for triage of low grade cervical cytology","volume":"122","author":"Kisser","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.jasc.2024.09.003_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cncy.21205","article-title":"p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: A systematic review and meta-analysis","volume":"120","author":"Roelens","year":"2012","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib29","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/jnci\/djt235","article-title":"Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: Results of the PALMS study","volume":"105","author":"Ikenberg","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2024.09.003_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2024.09.003_bib31","first-page":"12","article-title":"Triage for HPV screen-positives gets a boost","volume":"38","author":"Albert","year":"2024","journal-title":"CAP Today"},{"key":"10.1016\/j.jasc.2024.09.003_bib32","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/ijc.29290","article-title":"Triaging HPV-positive women with normal cytology by p16\/Ki-67 dual-stained cytology testing: baseline and longitudinal data","volume":"136","author":"Uijterwaal","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cncy.22385","article-title":"Determinants of p16\/Ki-67 adequacy and positivity in HPV-positive women from a screening population","volume":"129","author":"Benevolo","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib34","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1002\/cam4.3399","article-title":"Implementation of p16\/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience","volume":"9","author":"Hammer","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jasc.2024.09.003_bib35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2024.09.003_bib36","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","article-title":"Using biomarkers as objective standards in the diagnosis of cervical biopsies","volume":"34","author":"Galgano","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib37","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","article-title":"p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia","volume":"26","author":"Klaes","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2559.2002.01465.x","article-title":"Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia","volume":"41","author":"Cameron","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.jasc.2024.09.003_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/PGP.0b013e31820a79b0","article-title":"Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri","volume":"30","author":"Negri","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/cncy.22628","article-title":"Evaluation of p16\/Ki-67 dual-stain as triage test for high-risk HPV-positive women: A hospital-based cross-sectional study","volume":"130","author":"Chen","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.33812","article-title":"Clinical validation of p16\/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial","volume":"150","author":"Wright","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","article-title":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial","volume":"144","author":"Wright","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2024.09.003_bib43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamainternmed.2019.0306","article-title":"Clinical evaluation of Human Papillomavirus screening with p16\/Ki-67 dual stain triage in a large organized cervical cancer screening program","volume":"179","author":"Wentzensen","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jasc.2024.09.003_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jnci\/djaa105","article-title":"p16\/ki67 and E6\/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive women","volume":"113","author":"Giorgi Rossi","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2024.09.003_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2024.09.003_bib46","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.3390\/ijms24087158","article-title":"Triaging HPV-positive cervical samples with p16 and Ki-67 dual stained cytology within an organized screening program-A prospective observational study from western Norway","volume":"24","author":"Ovestad","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jasc.2024.09.003_bib47","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/modpathol.2017.16","article-title":"Evaluation of p16\/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women","volume":"30","author":"Ebisch","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/modpathol.2016.80","article-title":"p16\/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population","volume":"29","author":"Luttmer","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib49","doi-asserted-by":"crossref","first-page":"21181","DOI":"10.18632\/oncotarget.8307","article-title":"Evaluation of p16\/Ki-67 dual staining in detection of cervical precancer and cancers: A multicenter study in China","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jasc.2024.09.003_bib50","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-17-0534","article-title":"Defining optimal triage strategies for hrHPV screen-positive women-An evaluation of HPV 16\/18 genotyping, cytology, and p16\/Ki-67 cytoimmunochemistry","volume":"26","author":"Stanczuk","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jasc.2024.09.003_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29271","article-title":"p16\/Ki67 dual stain triage versus cytology in primary Human Papillomavirus-based cervical cancer screening with limited genotyping","volume":"95","author":"Trzeszcz","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.jasc.2024.09.003_bib52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-018-2432-z","article-title":"Dual staining for p16\/Ki67 is a more specific test than cytology for triage of HPV-positive women","volume":"473","author":"Arean-Cuns","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jasc.2024.09.003_bib53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1471-0528.17248","article-title":"Clinical utility of p16\/Ki67 dual-stain cytology for detection of cervical intraepithelial neoplasia grade two or worse in women with a transformation zone type 3: A cross-sectional study","volume":"130","author":"Gustafson","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.jasc.2024.09.003_bib54","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/ijc.33858","article-title":"Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population","volume":"150","author":"Gustinucci","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/LGT.0000000000000802","article-title":"Recommendations for use of p16\/Ki67 Dual Stain for management of individuals testing positive for Human Papillomavirus","volume":"28","author":"Clarke","year":"2024","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2024.09.003_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cncy.22498","article-title":"A positive HPV test with positive p16\/Ki-67 double staining in self-sampled vaginal material is an accurate tool to detect women at risk for cervical cancer","volume":"130","author":"Lorenzi","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.003_bib57","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cmi.2019.10.020","article-title":"Evaluation of p16\/Ki-67 dual-stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer","volume":"26","author":"Toliman","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jasc.2024.09.003_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jnci\/djaa066","article-title":"Accuracy and efficiency of deep-learning-based automation of Dual Stain cytology in cervical cancer screening","volume":"113","author":"Wentzensen","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2024.09.003_bib59","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1158\/0008-5472.CAN-22-0657","article-title":"Early insights into cancer epigenetics: Gene promoter hypermethylation emerges as a potential biomarker for cancer detection","volume":"82","author":"Clark","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.jasc.2024.09.003_bib60","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet"},{"key":"10.1016\/j.jasc.2024.09.003_bib61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s11658-021-00290-9","article-title":"Laboratory methods to decipher epigenetic signatures: A comparative review","volume":"26","author":"Halabian","year":"2021","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.jasc.2024.09.003_bib62","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","article-title":"Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): A systematic review and meta-analysis","volume":"121","author":"Kelly","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13148-023-01537-2","article-title":"DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: A systematic review and meta-analysis","volume":"15","author":"Salta","year":"2023","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jasc.2024.09.003_bib64","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/ijc.30008","article-title":"Validation of a DNA methylation HPV triage classifier in a screening sample","volume":"138","author":"Lorincz","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib65","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ijc.34050","article-title":"DNA methylation testing with S5 for triage of high-risk HPV positive women","volume":"151","author":"Adcock","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib66","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/ijc.31976","article-title":"Evaluation of a validated methylation triage signature for Human Papillomavirus positive women in the HPV FOCAL cervical cancer screening trial","volume":"144","author":"Cook","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ijc.33815","article-title":"Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study","volume":"150","author":"Banila","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib68","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13148-019-0743-9","article-title":"Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16\/18 genotyping","volume":"11","author":"Hernandez-Lopez","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jasc.2024.09.003_bib69","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/ijc.33314","article-title":"Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country","volume":"148","author":"Ramirez","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13148-020-00849-x","article-title":"Evaluation of a methylation classifier for predicting pre-cancer lesion among women with abnormal results between HPV16\/18 and cytology","volume":"12","author":"Gu","year":"2020","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jasc.2024.09.003_bib71","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.33320","article-title":"Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study","volume":"148","author":"Bonde","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib72","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.cmi.2020.03.018","article-title":"FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: Cross-sectional and longitudinal data from a Dutch screening cohort","volume":"27","author":"Vink","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jasc.2024.09.003_bib73","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up","volume":"143","author":"De Strooper","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib74","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1200\/JCO.21.02433","article-title":"Clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4\/miR124-2 DNA methylation (CONCERVE Study)","volume":"40","author":"Kremer","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jasc.2024.09.003_bib75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.34913","article-title":"Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort","volume":"155","author":"Gilham","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00286-21","article-title":"Clinical and analytical evaluation of the Alinity m HR HPV Assay within the VALGENT-3 framework","volume":"59","author":"Dhillon","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jasc.2024.09.003_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.104851","article-title":"Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening setting","volume":"140","author":"Ostrbenk Valencak","year":"2021","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jasc.2024.09.003_bib78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2023.01.004","article-title":"Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the onclarity trial","volume":"170","author":"Stoler","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2024.09.003_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100293","article-title":"A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs","volume":"22","author":"Demarco","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jasc.2024.09.003_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/LGT.0000000000000573","article-title":"Human Papillomavirus same genotype persistence and risk: A systematic review","volume":"25","author":"Bonde","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2024.09.003_bib81","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmi.2020.03.033","article-title":"Commercially available molecular tests for human papillomaviruses: A global overview","volume":"26","author":"Poljak","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jasc.2024.09.003_bib82","article-title":"Correlation between Human Papillomavirus viral load and cervical lesions classification: A review of current research","volume":"10","author":"Zhou","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.jasc.2024.09.003_bib83","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1055-9965.EPI-19-0239","article-title":"New Mexico HPVPRSC. Role of HPV genotype, multiple infections, and viral load on the risk of high-grade cervical neoplasia","volume":"28","author":"Adcock","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jasc.2024.09.003_bib84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygyno.2017.11.016","article-title":"Human Papillomavirus viral load as a useful triage tool for non-16\/18 high-risk human papillomavirus positive women: A prospective screening cohort study","volume":"148","author":"Dong","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2024.09.003_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232117","article-title":"The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer","volume":"15","author":"Duan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2024.09.003_bib86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/LGT.0000000000000277","article-title":"Evaluation of viral load as a triage strategy with primary high-risk Human Papillomavirus cervical cancer screening","volume":"21","author":"Luo","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2024.09.003_bib87","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12985-019-1253-2","article-title":"HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia","volume":"16","author":"Berggrund","year":"2019","journal-title":"Virol J"},{"key":"10.1016\/j.jasc.2024.09.003_bib88","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/ijc.30238","article-title":"Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer","volume":"139","author":"Depuydt","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2024.09.003_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/CEJ.0000000000000241","article-title":"Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring Human Papillomavirus-induced pathway","volume":"26","author":"Verhelst","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jasc.2024.09.003_bib90","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1055-9965.EPI-18-0802","article-title":"Changes in DNA level of oncogenic Human Papillomaviruses other than types 16 and 18 in relation to risk of cervical intraepithelial neoplasia grades 2 and 3","volume":"28","author":"Xi","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T16:43:43Z","timestamp":1735663423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294524002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213294524002138"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2024.09.003","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triage options for positive high-risk HPV results from HPV-based cervical cancer screening: a review of the potential alternatives to Papanicolaou test cytology","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2024.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society of Cytopathology\u00e9","name":"copyright","label":"Copyright"}]}}